Related Experiment Video
Updated: Jul 16, 2026
05:23
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
[Genetic iron overload diseases: a deeply changing world].
Pierre Brissot1, Marie-Bérengère Troadec, Caroline Le Lan
1Service des maladies du foie, Unité INSERM U-522 et IFR 140, hôpital Pontchaillou, rue Henri-le-Guillou, 35033 Rennes. pierre.brissot@univ-rennes1.fr
Nephrologie & Therapeutique
|March 22, 2007
Summary
Iron overload diseases, including common HFE-related and rare types, stem from altered iron absorption or egress, often linked to low hepcidin. Understanding these mechanisms advances treatments beyond phlebotomy.
Area of Science:
- Genetics and molecular biology
- Hematology
- Internal Medicine
Context:
- Iron overload diseases are evolving rapidly due to genetic and molecular biology advancements.
- Five main types exist: HFE-related (type 1) and rare types 2, 3, 4 haemochromatosis, and aceruloplasminemia.
- These conditions involve cellular iron excess or decreased iron egress.
Purpose:
- To review the pathophysiology of iron overload diseases.
- To categorize the genetic and molecular mechanisms underlying different haemochromatosis types and aceruloplasminemia.
- To highlight the role of hepcidin and non-transferrin-bound iron.
Summary:
- HFE-related, type 2, and type 3 haemochromatosis involve increased duodenal iron absorption and macrophagic recycling due to hypo-hepcidinemia.
- Type 4 haemochromatosis and aceruloplasminemia are characterized by decreased cellular iron egress.
- Non-transferrin-bound iron contributes to cellular damage in iron overload.
Impact:
- Phlebotomy remains a key treatment for iron overload disorders.
- Improved understanding of disease mechanisms paves the way for novel therapeutic strategies.
- Advances in genetics and molecular biology are crucial for diagnosing and managing these conditions.
Related Concept Videos
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
00:49What is Genetic Engineering?
Overview
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:39Mutations
Overview
01:35Mutations
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...